Onset, Duration, and Management of Edema and Effusion in Patients Treated With Loncastuximab Tesirine for R/R DLBCL: Updated Results From the LOTIS-2 Clinical Trial

Email this document.

Enter your email address below to send this document.

PLACEHOLDER START

[ninja_form id=1]

Important Notice